Description

Neorustmicin D CAS NO 104169-50-8 is a specialized macrolide antibiotic compound of significant interest in pharmaceutical research and development. Its core value lies in its potent biological activity, which makes it a crucial intermediate and reference standard for studying novel antimicrobial agents. This product is essential for research institutions, pharmaceutical companies, and biotechnology firms engaged in drug discovery, particularly for targeting resistant bacterial strains. Its high purity and well-defined structure are critical for ensuring the accuracy and reproducibility of experimental results.

Application

• Pharmaceutical Research & Development: Serves as a key reference standard and building block in the discovery and synthesis of new antibiotic candidates.
• Antimicrobial Mechanism Studies: Used in biochemical and microbiological assays to investigate the mode of action against specific bacterial targets.
• Analytical Chemistry: Employed as a certified reference material (CRM) for method development and validation in HPLC, LC-MS, and other analytical techniques.
• Preclinical Studies: Utilized in in vitro and in vivo studies to evaluate the efficacy, pharmacokinetics, and toxicity profiles of related compounds.
• Academic Research: A vital tool for universities and research institutes studying macrolide biosynthesis, structure-activity relationships (SAR), and bacterial resistance.
• Biotechnology: May be used in enzyme inhibition studies or as a selective agent in microbial culture media.

Basic Information

Product Name	Neorustmicin D
CAS No.	104169-50-8
Molecular Formula	C36H61NO12
Molecular Weight	699.88 g/mol
Synonyms	Neorustmicin D; Antibiotic A 26771B; L 156,602; (2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10,14-tetrahydroxy-5,11,13-trimethyl-8-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1-oxacyclotetradecane-6,12-dione; 16-Ethyl-4,5,13,15-tetrahydroxy-3,7,11-trimethyl-14-[(2,3,4,6-tetradeoxy-3-C-methyl-4-O-methyl-α-L-erythro-hexopyranosyl)oxy]oxacyclotetradecane-2,8-dione
EINECS	Contact for details

Quality Control

Our Neorustmicin D is produced and handled under strict quality management protocols to ensure batch-to-batch consistency and high purity, suitable for research applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to relevant industry standards for reference materials, and our quality systems are designed to support the stringent requirements of pharmaceutical R&D. Certificates of Analysis (COA) are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below for long-term stability. For short-term use, the product may be stored at 2-8°C. The container should be kept in a dry, well-ventilated area. Allow the sealed vial to equilibrate to room temperature before opening to prevent condensation and moisture uptake.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (MS)	Conforms to reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.